Wioleta Respondek

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing's disease with eventual hypercortisolism relapse: Case Report and literature review.

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing's disease with eventual hypercortisolism relapse: Case Report and literature review.

Journal: Frontiers in medicine

Published: May 15, 2025

Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.

Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.

Journal: Journal of clinical medicine

Published: March 04, 2025

A rare manifestation of adrenocortical carcinoma as a mimic of pheochromocytoma: a case report and literature review.

A rare manifestation of adrenocortical carcinoma as a mimic of pheochromocytoma: a case report and literature review.

Journal: Frontiers in endocrinology

Published: November 24, 2024

Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.

Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.

Journal: Endocrine

Published: August 14, 2024

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Journal: Frontiers in endocrinology

Published: November 14, 2023

Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center.

Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center.

Journal: Biomedicines

Published: November 02, 2023

Ectopic ACTH syndrome in the course of ACTH-secreting pancreatic neuroendocrine tumour in a patient with a pituitary lesion - diagnostic challenges and individual approach.

Ectopic ACTH syndrome in the course of ACTH-secreting pancreatic neuroendocrine tumour in a patient with a pituitary lesion - diagnostic challenges and individual approach.

Journal: Endokrynologia Polska

Published: September 10, 2023

Pituitary apoplexy as the first manifestation of non‑functioning pituitary neuroendocrine tumour.

Pituitary apoplexy as the first manifestation of non‑functioning pituitary neuroendocrine tumour.

Journal: Endokrynologia Polska

Published: July 27, 2023

Cushing's syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia.

Cushing's syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia.

Journal: Hormones (Athens, Greece)

Published: July 06, 2022

Nutrition and lifestyle in patients pharmacologically treated due to hypertension.

Nutrition and lifestyle in patients pharmacologically treated due to hypertension.

Journal: Cardiology journal

Published: December 16, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026